SAMUEL PONIACHIK: Open Payments
NPI 1467485078 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 28 payments from 5 companies in 2025. Trend: 2023 $1,001 · 2024 $516 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $245 |
| EMD Serono, Inc. | 5 | $172 |
| ViiV Healthcare Company | 3 | $58 |
| Novo Nordisk Inc | 2 | $49 |
| Alkermes, Inc. | 1 | $22 |
Products named: Serostim, Yeztugo, Rybelsus, CABENUVA, VIVITROL, Biktarvy, DOVATO.
Industry payments across CA — which companies pay providers there.
